Skip to content

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Dec 2025

The impact of biological and targeted synthetic disease-modifying antirheumatic drugs on patient costs: a cross-sectional study.

OBJECTIVES Financial toxicity, defined as the detrimental impact of treatment-related costs on patients' lifestyles, has gained increasing recognition and is now managed similarly to treatment-related physical toxicities. We aimed to investigate the association between the use of biologic or targeted synthetic disease-...

R. Takahashi, N. Yajima, Toshihisa Kojima et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.